@FierceBiotech: Experts puzzled over low turnout in cancer trials. Story | Follow @FierceBiotech
@JohnCFierce: The ultimate virtual biotech? Halo scouts for funds to finance mid-stage DMD trial. Not a genetic fix, either. Piece | Follow @JohnCFierce
@RyanMFierce: Google VC doubles down on Big Data after biotech bets. Article | Follow @RyanMFierce
> Synta Pharmaceuticals announced a pact to collaborate with the Multiple Myeloma Research Consortium on a clinical trial of its second-gen Hsp90 inhibitor. The Multiple Myeloma Research Foundation is providing up to a million dollars for the study. Report
> In an ongoing restructuring, Canada's Cangene announced that its CFO has left the company. In January, Cangene axed 120 workers. Story
> Aveo Pharmaceuticals says it has published the results from a successful Phase II clinical trial evaluating the efficacy and safety of tivozanib in 272 patients with advanced renal cell carcinoma in the Journal of Clinical Oncology. Release
Pharma News
@FiercePharma: Budget cuts in Europe squeeze Roche's regional sales 4%, but US growth of 6% more than offsets it--Reuters. News | Follow @FiercePharma
> J&J's $1.2B Risperdal fine 'ups the ante' for other cases. Story
> Roche sales flat for Q1, but cancer meds shine. Report
> Reuters: Watson aims for Actavis deal this month. Item
> Sales-rep overtime steps into Supreme Court. Article
Medical Devices News
@FierceMedDev: Quest Diagnostics Names Steve Rusckowski as President and CEO. Release | Follow @FierceMedDev
> Quest snags Philips Healthcare head as new CEO. News
> FDA panel wants U-Systems' breast ultrasound approved. Article
> Irish researchers look to up angioplasty success rates. Item
> Sony slashes jobs, boosts med equipment focus. Story
Manufacturing News
> Surya Pharmaceuticals closes 2 Indian API plants. Story
> 3 big animal drugmakers volunteer to change labels. News
> Some supply issues expected from Teva plant in Croatia. More
> Hospira taps drug industry veteran to oversee operations. Article
CRO News
> FDA issues warning to BioMed IRB over its practices. More
> eResearch Technology goes private as lawyers investigate acquisition. Article
> Experts puzzled over low turnout in cancer trials. Story
Vaccines News
> Intellect Neurosciences chases Holy Grail of Alzheimer's: a preventive vaccine. Commentary
> GAVI signs deal for diarrhea vax for world's poorest. Article
> Asthma vaccine hopes rise in preclinical trials. Story
> Vaccine approach could trick immune system. Item
> 'Universal' cancer vaccine not miraculous but could bring hope. More
And Finally... A new study from Michigan State concludes that almost a third of all injuries sustained by college athletes is the result of "overuse." Story